[1] |
Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses[J]. Annu Rev Immunol,2004,22:531-562. doi: 10.1146/annurev.immunol.21.120601.141122
|
[2] |
Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells[J]. Science,2003,299(5609):1033-1036. doi: 10.1126/science.1078231
|
[3] |
Kong N, Lan Q, Chen M, et al. Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance[J]. Arthritis Rheum,2012,64(8):2548-2558. doi: 10.1002/art.34513
|
[4] |
Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease[J]. Dev Cell,2006,11(4):441-450. doi: 10.1016/j.devcel.2006.09.009
|
[5] |
Brodersen P, Voinnet O. Revisiting the principles of microRNA target recognition and mode of action[J]. Nat Rev Mol Cell Biol,2009,10(2):141-148. http://cn.bing.com/academic/profile?id=1995073275&encoded=0&v=paper_preview&mkt=zh-cn
|
[6] |
Davis BN, Hata A. Regulation of microRNA biogenesis: a miRiad of mechanisms[J]. Cell Commun Signal,2009,7:18. doi: 10.1186/1478-811X-7-18
|
[7] |
Lu LF, Thai TH, Calado DP, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein[J]. Immunity,2009,30(1):80-91. doi: 10.1016/j.immuni.2008.11.010
|
[8] |
Kohlhaas S, Garden OA, Scudamore C, et al. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells[J]. J Immunol,2009,182(5):2578-2582. doi: 10.4049/jimmunol.0803162
|
[9] |
Yao R, Ma YL, Liang W, et al. MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1[J]. PLoS One,2012,7(10):e46082. doi: 10.1371/journal.pone.0046082
|
[10] |
Zhang M, Zhang Q, Liu F, et al. MicroRNA-155 may affect allograft survival by regulating the expression of suppressor of cytokine signaling 1[J]. Med Hypotheses,2011,77(4):682-684. doi: 10.1016/j.mehy.2011.07.016
|
[11] |
Hori S. Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells[J]. Immunol Rev,2014,259(1):159-172. doi: 10.1111/imr.12175
|
[12] |
Gołąb K, Krzystyniak A, Marek-Trzonkowska N, et al. Impact of culture medium on CD4(+) CD25(high)CD127(lo/neg) Treg expansion for the purpose of clinical application[J]. Int Immunopharmacol,2013,16(3):358-363. doi: 10.1016/j.intimp.2013.02.016
|
[13] |
Collins EL, Jager LD, Dabelic R, et al. Inhibition of SOCS1-/- lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis[J]. J Immunol,2011,187(5):2666-2676. doi: 10.4049/jimmunol.1003819
|
[14] |
Cobb BS, Hertweck A, Smith J, et al. A role for Dicer in immune regulation[J]. J Exp Med,2006,203(11):2519-2527. doi: 10.1084/jem.20061692
|
[15] |
Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection[J]. Cell,2007,129(1):147-161. doi: 10.1016/j.cell.2007.03.008
|
[16] |
O'Connell RM, Rao DS, Chaudhuri AA, et al. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder[J]. J Exp Med,2008,205(3):585-594. doi: 10.1084/jem.20072108
|
[17] |
O'Connell RM, Chaudhuri AA, Rao DS, et al. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output[J]. Proc Natl Acad Sci U S A,2010,107(32):14235-14240. doi: 10.1073/pnas.1009798107
|
[18] |
Vigorito E, Perks KL, Abreu-Goodger C, et al. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells[J]. Immunity,2007,27(6):847-859. doi: 10.1016/j.immuni.2007.10.009
|
[19] |
Stanczyk J, Pedrioli DM, Brentano F, et al. Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis[J]. Arthritis Rheum,2008,58(4):1001-1009. doi: 10.1002/art.23386
|
[20] |
Cooles FA, Isaacs JD, Anderson AE. Treg cells in rheumatoid arthritis: an update[J]. Curr Rheumatol Rep,2013,15(9):352. doi: 10.1007/s11926-013-0352-0
|
[21] |
Szodoray P, Nakken B, Barath S, et al. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders[J]. Hum Immunol,2013,74(12):1510-1518. doi: 10.1016/j.humimm.2013.08.003
|
[22] |
Dons EM, Raimondi G, Cooper DK, et al. Induced regulatory T cells: mechanisms of conversion and suppressive potential[J]. Hum Immunol,2012,73(4):328-334. doi: 10.1016/j.humimm.2011.12.011
|